 |
|
|
MEMBER DIRECTORY
Created in response to popular demand, this directory allows you to search our registered
membership by name, geographic location and clinical and research interests. We
urge all visitors to register. It's free, and by registering, members can help build
our online community, receive our email newsletter, find colleagues and collaborators,
and form groups focused on specific interests.
RESEARCHER PROFILES
As part of our community-building effort, we are offering this tool to allow researchers
to create a personal web page describing their research background, accomplishments
and current ideas about Alzheimer research, as well as share some personal details
that reveal something about the person behind the by-line. Click here to view existing
profiles. To create or edit your own profile, you must first be registered in our
Member Directory.
INSTITUTES AND LABS
An index of institutes and individual laboratory web sites. Inclusion in the index
is free and open to all organizations that are engaged in research of relevance
to Alzheimer researchers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Join us on Tuesday, 14 September 2010 at noon, U.S. Eastern Daylight Saving Time, for a Webinar, Microdissection and Microarrays: Analyzing Selective Cell Vulnerability.
Check out our most recent Webinar/Live Discussion: Untapped Resource? New Study to Boost Acceptance of CSF Analysis, held 5 August 2010.
Check out our Webinar/Live Discussion: Together at Last, Top Five Biomarkers Model Stages of AD, held 21 January 2010.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
